Skip to main content
. 2018 Jun;154:132–139. doi: 10.1016/j.antiviral.2018.04.015

Fig. 2.

Fig. 2

Presence of AHSV-VP2 protein in the MVA-VP2 vaccines’ preparations. Immunoblotting of vaccine inoculum (left panel: first vaccination experiment; right panel: second vaccination experiment) was performed using a VP2-specific rabbit polyclonal antibody following SDS-PAGE separation of proteins. Arrowhead indicates the expected size of AHSV-4 VP2.